Table 2.
HR and RMSSD means and standard deviations for vigorous exercise groups under each treatment for rest and stress conditions.
| Low vigorous activity | %Δ | High vigorous activity | %Δ | ||||
|---|---|---|---|---|---|---|---|
| Placebo M (SD) | Drug M (SD) | Placebo M (SD) | Drug M (SD) | ||||
| HR | Rest | 74.13 (8.56) | 69.43 (6.93) | −6.3 | 67.84 (14.10) | 64.45 (11.83) | −5 |
| Stress | 94.80 (10.45) | 84.12 (10.03) | −11.2 | 84.62 (17.93) | 81.34 (15.21) | −3.9 | |
| %Δ | 27.9 | 21.2 | 24.7 | 26.2 | |||
| RMSSD | Rest | 49.03 (24.80) | 48.79 (23.77) | −0.4 | 61.22 (37.45) | 59.27 (31.41) | −3.2 |
| Stress | 31.27 (14.18) | 38.25 (18.17) | 22.3 | 42.94 (32.81) | 43.13 (33.45) | 0.4 | |
| %Δ | −36.2 | −21.6 | −29.9 | −27.2 | |||